Should You Buy, Hold, or Sell BMY Stock Ahead of Q1 Earnings?

Biotech giant Bristol-Myers Squibb Company (BMY) is scheduled to report first-quarter 2025 results on April 24, before market open. The Zacks Consensus Estimate for sales and earnings is pegged at $10.74 billion and$1.54 per share, respectively.Earnings estimate for 2025 has increased to $6.78 from$6.75 per share over the past 30 days, while that for 2026 has decreased to $6.06 from$6.08. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)Image Source: Zacks Investment ResearchBMY’s ...